Member Info for Pingu777

It will be ASAP.

Patient sign-up driving timescales as far as I am aware. Everything else just about in place.

The rise doesn’t have to be immediate.

HEMO has ticked another milestone off.

They are huge strides closer to owning a multi multi million dollar drug. Most drugs fail pre clinical.

HEMO marches towards to success. The door is open to huge growth. The clock is ticking til the SO explodes.

You’ll be back on Twitter when you’ve bought back in waxing lyrical and kissing Vlad’s ass ;-)

I can remember when the trolls were much better at their jobs.

Where have you been for he last couple of days Stu? Twitter? Sold up and on the whiny whine now. Like reading a book ;-)

One2one, Addressing the current situation, HEMO is a stones throw from going clinical with a new CAR T treatment for leukemia. Whether you like it or not! Deal with it!

Excellent discovery in terms of your reading.

We have worked with both J&J and their subsidiary Jansssen. Existing links make this a situation that is not out of the question.

The potential for a multi-bag here over the next weeks are impossible to ignore.

After a SprintRS finish, it will be less days ;-)

From the RNS

"Once the clinical investigation plan proposed in the IND submission has been cleared to proceed by the FDA, the Company plans to initiate a Phase I clinical trial of HEMO-CAR-T."

Positive language from Vlad, 'once', not 'if'.. After checking the app for months he's very confident hes got it all spot on. The language also reflects the nature of FDAs checks at this stage. After having ongoing dialogue with FDA during the pre IND app process they will know exactly how HEMO are looking with all of the requirements as well as HEMO knowing they they have met all that has been asked of them by the FDA in terms of the app.

Time to buy a few more.

500k was a buy in my opinion. But Im no trade guru.

Hoping for more buying pressure tomorrow. Be nice get a cheeky little RNS.

The bots are everywhere... trust no-one! haha

Stu's right...
It's utter madness to consider that the SP might go up when HEMO unlock the door to trials and potential commercialisation. Plus all the other comms that will follow. It's obviously going to be such a negative period. (This sarcasm, to be clear)
Lol

Its red or black if you dont do any research. Imo.

We will get there. Whatever waffle is peddled on here. Timescales are frustrating, this is undeniable. It takes a long time to create true innovation.

Is it worth a few years wait if your stock 10/20 bags and more? You tell me. If you trust your research and that HEMO has the magic combination, then whatever timescales are required to deliver are justified.

It makes sense to many of us humble, nobody investors that, if at all possible, HEMO would be applying for whatever grants they are able to get their hands on.

Maybe they are waiting til the CAR T IND app is submitted and work is completed with this task before beginning another project like meeting the grant requirements? Maybe reaching the clinic with CAR T will open up some doors with the obtaining of some material non-dilutive funding?

Choosing not to apply for essentially 'free funding' would be a very odd play for such a prudent man as Vlad.

Vlad's masterminding things. FDA IND apps are a big deal. HEMO is a low resourced junior pharma... Deal with it!

Be brave when others are fearful!

I'm annoyed as the next person how Vlad can leave his investors in the dark. Nothing RNSable since the raise... hmmm

Trust him and be patient is Vlad's mantra. It's certainly not changed! and I do, completely. But there is no doubt patience is being tested. We will get there, 100% not if, but when... but this lull is dull.

Agreed. Big order filling shenanigans helping the rich, not helping the minions!

Cant find any link of this nature.
I'd assume there is a lot of dialogue with FDA though. Its kind of a big deal bringing novel cancer treatments to trial!

How about you Stu? Any insight on the paper Hulver linked? Im interested to hear your views.

Not sure what you are looking for from me? Its complex.

Its a paper documenting the potential advancements in their CAR T treatment? From 16 months ago. Exploring adding a second types of treatment along with CAR T down the line.

I notice the paper was produced with HEMO and Novartis, both PENN partners. Hope Novartis like Vlad's work ;-)

Pretty sure there'd be one pumpky if they were not accepted. You know Vlad doesnt like undoing the purse strings for an RNS for micro stages. Indications are, as things stand, knowing the earlier runs were fine, that all is well. Unless you like a witter?
One2one, so you're saying HEMO will have something to offer once it enters clinical trials... good stuff. Shouldn't be long now.